Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
23%
Adverse Event
7%
Antibiotics
23%
Apixaban
8%
Autoimmune Hepatitis
9%
Chronic Kidney Failure
22%
Cohort Study
47%
Combination Therapy
9%
Comorbidity
5%
Dabigatran
8%
Diabetes Mellitus
5%
Direct Oral Anticoagulant
23%
Edoxaban
8%
Gastroenterology
23%
Health Status
5%
Hepatitis E Virus
5%
Immunogenicity
5%
Immunosuppressive Agent
64%
Inflammatory Bowel Disease
9%
Kidney Failure
5%
Liver Cirrhosis
23%
Long Term Survival
11%
Mycophenolate Mofetil
23%
Mycophenolic Acid
28%
Observational Study
11%
Pharmacodynamics
28%
Pharmacokinetics
28%
Pharmacotherapy
23%
Prevalence
39%
Randomized Controlled Trial
53%
Rapamycin
47%
Ribavirin
5%
Side Effect
5%
Tacrolimus
100%
Therapeutic Drug Monitoring
45%
Viral Clearance
5%
Medicine and Dentistry
Adverse Drug Reaction
11%
Autoimmune Hepatitis
11%
Azathioprine
5%
Cohort Analysis
47%
Cohort Study
11%
Drug Dose Regimen
5%
Drug Use
5%
Gastroenterology
23%
Hepatology
23%
Immunosuppressant
17%
Immunosuppressive Drug
29%
Immunosuppressive Treatment
23%
Inflammatory Bowel Disease
11%
Liver Graft
71%
Liver Transplantation
21%
Long Term Survival
5%
Mammalian Target of Rapamycin Inhibitor
5%
Medication Compliance
29%
Medicine
23%
Mycophenolic Acid
5%
Observational Study
5%
Outpatient
47%
Pharmacodynamics
5%
Prevalence
29%
Quality of Life
23%
Rapamycin
23%
Tacrolimus
29%
Therapeutic Drug Monitoring
23%
Visual Analog Scale
6%
Nursing and Health Professions
Adverse Drug Reaction
11%
Chronic Kidney Failure
10%
Clinical Pharmacist
47%
Cohort Analysis
47%
Combination Therapy
6%
Compliance
11%
Drug Dose Regimen
5%
Drug Use
5%
Estimated Glomerular Filtration Rate
10%
Immunosuppressive Agent
5%
Immunosuppressive Treatment
23%
Liver Graft
95%
Liver Transplantation
9%
Long Term Survival
5%
Low Drug Dose
27%
Medication Compliance
21%
Medication Therapy Management
5%
Outpatient
47%
Outpatient Department
5%
Prevalence
21%
Quality of Life
23%
Rapamycin
47%
Tacrolimus
47%
Visual Analog Scale
6%
